Medista
Medista, officially known as Medista Pharmaceuticals, is a prominent player in the pharmaceutical industry, headquartered in Turkey (TR). Founded in 2015, the company has rapidly established itself as a key provider of high-quality generic medications and innovative healthcare solutions across various operational regions, including Europe and the Middle East. Specialising in a diverse range of therapeutic areas, Medista is recognised for its commitment to quality and affordability. The company’s core products include generic drugs that meet stringent international standards, setting them apart in a competitive market. With a focus on research and development, Medista has achieved significant milestones, enhancing its market position and reputation for excellence in the pharmaceutical sector.
DitchCarbon Score
How does Medista's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medista's score of 3 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medista's reported carbon emissions
Medista, headquartered in Turkey (TR), currently does not have available carbon emissions data for recent years. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. However, the company is committed to addressing climate change through various initiatives, although no specific reduction targets or climate pledges have been disclosed. In the absence of detailed emissions data, it is essential for Medista to establish clear climate commitments and reduction strategies to align with industry standards and contribute to global sustainability efforts.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medista is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
